NASDAQ: BCRXBiocryst Pharmaceuticals Inc Stock Ownership - Who owns Biocryst Pharmaceuticals?
Insider buying vs selling
Have Biocryst Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Helen M. Thackray | Chief RD Officer | 2024-03-31 | 7,525 | $5.08 | $38.23kSell |
| Theresa Heggie | Director | 2024-02-29 | 999 | $5.63 | $5.62kBuy |
| Vincent Milano | Director | 2024-02-29 | 999 | $5.63 | $5.62kBuy |
| Charles K. Gayer | Chief Commercial Officer | 2023-12-19 | 2,482 | $6.05 | $15.02kSell |
| Jon P. Stonehouse | President CEO | 2023-12-19 | 14,089 | $6.05 | $85.24kSell |
| Helen M. Thackray | Chief RD Officer | 2023-12-19 | 5,580 | $6.05 | $33.76kSell |
| Anthony Doyle | Chief Financial Officer | 2023-12-19 | 2,482 | $6.05 | $15.02kSell |
| Alane P. Barnes | Chief Legal Officer | 2023-12-19 | 2,482 | $6.05 | $15.02kSell |
| Alane P. Barnes | Chief Legal Officer | 2023-12-14 | 4,015 | $6.43 | $25.82kSell |
| Anthony Doyle | Chief Financial Officer | 2023-12-14 | 5,475 | $6.43 | $35.20kSell |
BCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BCRX insiders and whales buy or sell their stock.
BCRX Shareholders
What type of owners hold Biocryst Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Bros Advisors LP | 10.45% | 21,543,334 | $91.99M | Insider |
| Blackrock Inc | 9.06% | 18,681,370 | $79.77M | Institution |
| Vanguard Group Inc | 8.62% | 17,763,720 | $75.85M | Institution |
| Avoro Capital Advisors LLC | 6.33% | 13,050,000 | $55.72M | Institution |
| State Street Corp | 6.20% | 12,777,003 | $54.56M | Institution |
| Baker Bros Advisors LP | 4.91% | 10,126,176 | $43.24M | Institution |
| Braidwell LP | 2.77% | 5,718,477 | $24.42M | Institution |
| Kynam Capital Management LP | 2.23% | 4,600,000 | $19.64M | Institution |
| Deerfield Management Company LP Series C | 2.20% | 4,539,525 | $19.38M | Institution |
| Geode Capital Management LLC | 2.07% | 4,260,638 | $18.19M | Institution |
BCRX vs Biotech Stocks
Biocryst Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.